AGN's down after losing patent rights to Relistor. Stock will bottom at $160. $AGN, Allergan plc / H1 Related: VRX bottomed.TEVA is facing selling pressure.MYL is the best of the bunch.ENDP is stabilising.Login now and Agree or disagree.